Significance of measurement of prostate specific antigen (PSA) in familial prostate cancer lines

被引:2
|
作者
Ohtake, N
Nakata, S
Sato, J
Koya, A
Saruki, K
Kurihara, J
Tsuji, H
Imai, K
Yamanaka, H
Suzuki, K
Tari, K
机构
[1] Gunma Univ, Dept Urol, Sch Med, Gunma 3718511, Japan
[2] Gunma Univ, Sch Hlth Sci, Dept Lab Sci, Maebashi, Gumma 3718511, Japan
[3] Saitama Canc Ctr Hosp, Dept Urol, Ina, Saitama 3620806, Japan
来源
关键词
prostate cancer; family history; hereditary; serum prostate specific antigen (PSA); Japanese;
D O I
10.1620/tjem.184.21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The concentration of prostate specific antigen (PSA) in serum was measured in 20 brothers or sons in 10 families in which the father and son or brothers had prostate cancer using the E test TOSOH IIPA. The patients were between 32 and 70 years old with a mean age of 48.2 years. The PSA value was between 0.4 and 19.5 ng/ml with a mean value of 3.4 ng/ml. Five patients (25 %) had PSA values exceeding the cut-off value of 4.0 ng/ml. After obtaining their consent, systematic prostate needle biopsy by transrectal ultrasonography was performed on 3 patients (15 %). Prostate cancer was detected in all of them. Among them 2 patients were brothers, and since the other tyro brothers already had prostate cancer, all four brothers were confirmed to have prostate cancer. This is the first report of a familial prostate cancer in four brothers in Japan. In the western countries where the incidence of prostate cancer is higher than that in Japan, studies have been performed on the risk factors. Family history is one of the most important risk factors. In Japan, the incidence of prostate cancer is increasing rapidly. Moreover, patients with a prostate cancer family history are expected to increase. In such cases, prostate cancer screening should be performed aggressively from a young age. (C) 1998 Tohoku University Medical Press.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [1] The significance of prostate specific antigen (PSA) in breast cancer
    Klijn, JGM
    Diamandis, EP
    Yu, H
    Look, MP
    Gelder, MEMV
    van Putten, WLJ
    Foekens, JA
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S106 - S107
  • [2] Prostate cancer and prostate specific antigen (PSA) screening in Austria
    Vutuc, C
    Schernhammer, ES
    Haidinger, G
    Waldhör, T
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 (13-14) : 457 - 461
  • [3] Generation of prostate specific antigen (PSA)-reactive T cell lines implications for prostate cancer immunotherapy
    Klyushnenkova, EN
    Ponniah, S
    Mann, DL
    Alexander, RB
    [J]. FASEB JOURNAL, 2000, 14 (06): : A1005 - A1005
  • [4] Prostate specific antigen (PSA) as a predictor of biological behavior of prostate cancer
    Shohab, Durre
    Khawaja, Athar
    Jamil, Imran
    Rehman, Asadur
    Akhter, Saeed
    [J]. RAWAL MEDICAL JOURNAL, 2014, 39 (04): : 425 - 427
  • [5] Prostate specific antigen (PSA) as a diagnostic and prognostic marker of prostate cancer
    Simon, Ronald
    Kluth, Martina
    Fischer, Kristine
    Bonk, Sarah
    Hube-Magg, Claudia
    Hoflmayer, Doris
    Lennartz, Maximilian
    Lutz, Florian
    Sauter, Guido
    Buescheck, Franziska
    Uhlig, Ria
    Dum, David
    Luebke, Andreas M.
    Wittmer, Corinna
    Jacobsen, Frank
    Burandt, Eike
    Steurer, Stefan
    Minner, Waldemar Wilczakand Sarah
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [6] Heterogeneity in prostate cancer: Prostate specific antigen (PSA) and DNA cytophotometry
    Krause, FS
    Feil, G
    Bichler, KH
    Schrott, KM
    Akcetin, ZY
    Engehausen, DG
    [J]. ANTICANCER RESEARCH, 2005, 25 (3A) : 1783 - 1785
  • [7] The prostate specific antigen (PSA)
    Boissier, R.
    [J]. PROGRES EN UROLOGIE, 2011, 21 (11): : 798 - 800
  • [8] Prostate specific antigen (PSA) in breast and ovarian cancer
    Kucera, E
    Kainz, C
    Tempfer, C
    Zeillinger, R
    Koelbl, H
    Sliutz, G
    [J]. ANTICANCER RESEARCH, 1997, 17 (6D) : 4735 - 4737
  • [10] Prostate-specific antigen (PSA) and radiotherapy in locally confined prostate cancer
    Schaefer, U
    Micke, O
    Willich, N
    [J]. ANTICANCER RESEARCH, 1999, 19 (4A) : 2645 - 2648